MD2323F1 - Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma - Google Patents
Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myomaInfo
- Publication number
- MD2323F1 MD2323F1 MD20030151A MD20030151A MD2323F1 MD 2323 F1 MD2323 F1 MD 2323F1 MD 20030151 A MD20030151 A MD 20030151A MD 20030151 A MD20030151 A MD 20030151A MD 2323 F1 MD2323 F1 MD 2323F1
- Authority
- MD
- Moldova
- Prior art keywords
- uterine
- preparation
- isoturon
- uterotonic
- treatment
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to medicine, in particular to gynecology. Summary of the invention consists in using the S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma.The result of the invention consists in that for local use of said medicinal preparation in about 87% of cases it is attained a complete hemostasis in a reduced term and without side effects.Claims: 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030151A MD2323G2 (en) | 2003-06-23 | 2003-06-23 | Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030151A MD2323G2 (en) | 2003-06-23 | 2003-06-23 | Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma |
Publications (2)
Publication Number | Publication Date |
---|---|
MD2323F1 true MD2323F1 (en) | 2003-12-31 |
MD2323G2 MD2323G2 (en) | 2004-06-30 |
Family
ID=32026191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20030151A MD2323G2 (en) | 2003-06-23 | 2003-06-23 | Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD2323G2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2850G2 (en) * | 2005-02-18 | 2006-07-31 | Валентин ФРИПТУ | Method of inducing the medicamental abortion |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2491G2 (en) * | 2004-02-10 | 2005-01-31 | Виктор ГИКАВЫЙ | Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment |
MD3592G2 (en) * | 2007-11-06 | 2008-12-31 | Рафаэль Баркан | Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma |
MD3645G2 (en) * | 2008-01-10 | 2009-02-28 | Валентин ФРИПТУ | Method of treating uterine hypotonic postpartum hemorrhages |
MD668Z (en) * | 2013-02-22 | 2014-03-31 | Георге АНГЕЛИЧ | Method for conservative hemostasis of gastroduodenal hemorrhages |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD263C2 (en) * | 1995-03-01 | 1995-12-31 | Виктор ГИКАВЫЙ | "Isoturon" means with antihypotensive activity |
MD1431G2 (en) * | 1998-01-16 | 2001-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Antihypotensive remedies |
-
2003
- 2003-06-23 MD MDA20030151A patent/MD2323G2/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2850G2 (en) * | 2005-02-18 | 2006-07-31 | Валентин ФРИПТУ | Method of inducing the medicamental abortion |
Also Published As
Publication number | Publication date |
---|---|
MD2323G2 (en) | 2004-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
PL370111A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
IL154888A (en) | Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis | |
SE0001899D0 (en) | New compounds | |
MXPA03005340A (en) | Novel medicament compositions based on anticholinesterase drugs and on ciclesonides. | |
GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
MXPA05011208A (en) | Topical formulation of ivermectin for the treatment of dermatological conditions. | |
MX9605940A (en) | Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization. | |
GB2431346B (en) | A combination composition comprising paracetamol and ibuprofen | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
AU7862401A (en) | Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer | |
WO2001076601A3 (en) | Pharmaceutical compositions comprising salmeterol and ipratropium | |
MD2323F1 (en) | Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma | |
HK1087010A1 (en) | Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions | |
NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
PT1220676E (en) | PREVENTION OF COLORCECTAL CANCER | |
WO2003007876A3 (en) | N-fatty acid-amino acid conjugates and therapeutic uses | |
MXPA02008870A (en) | Novel lhrh antagonists, production and use thereof as medicament. | |
WO2005002617A3 (en) | Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases | |
IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
DE60318453D1 (en) | ANALGETICS FOR NEWBORN AND FAT | |
GB0128071D0 (en) | Medicament | |
MD2491F1 (en) | Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |